Dublin, Jan. 15, 2025 (GLOBE NEWSWIRE) — The “Dog Vaccines Market Size, Share & Trends Analysis Report By Vaccine Type, By Disease Type, By Route Of Administration, By Duration Of Immunity, By Component, By Region, And Segment Forecasts, 2025 – 2030” report has been added to ResearchAndMarkets.com’s offering.
The global dog vaccine market size is anticipated to reach USD 2.88 billion by 2030 and display a CAGR of 6.45% from 2025 to 2030.
The growth can be attributed to the increasing trend of pet humanization, pet ownership among millennials, and rising consciousness regarding preventive healthcare. According to Boehringer Ingelheim International, 35% of millennials and 32% of baby boomers own a pet. In addition, the rise in pet spending and insurance is also expected to add to the growth of this market. According to an article published by WorldAnimalFoundation.org in February 2023, dog owners spent approximately USD 570 more than cat owners.
Moreover, the increasing pet population, rising income levels in emerging markets of Asia-Pacific, such as China and India, and consequent changes in the lifestyle of people are expected to impact the growth of the dog vaccine industry significantly.
Dog Vaccine Market Report Highlights
- Based on vaccine type, the modified/attenuated live vaccine segment accounted for the largest revenue share of 52.03% in 2024, as they help prevent disease and provide long-term immunity.
- Based on disease type, the canine rabies segment is expected to grow at the fastest CAGR of 7.3% over the forecast period due to the high prevalence of this disease and its zoonotic potential.
- Based on route of administration, the oral vaccine segment is expected to grow at the fastest CAGR from 2025 to 2030.
- Based on duration of immunity, the 1-year segment dominated the market with a share of 51.2% in 2024 owing to their convenience.
- Based on component, the combined vaccines segment accounted for the largest market share of 65%. It is expected to grow at the fastest CAGR over the forecast period due to its ability to protect against more than one disease.
- North America dominated with a share of 38% in 2024, owing to the presence of major players and increasing awareness regarding preventive healthcare for pets. On the other hand, the Asia Pacific dogs vaccine market is expected to grow at the fastest CAGR over the forecast period.
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
Key market players in the dog insurance market include:
- Zoetis
- Boehringer Ingelheim
- Merck
- Elanco
- Virbac
- Bioveta
- Hester Biosciences
- Brilliant Bio Pharma
- Heska
- Zendal Group
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 150 |
| Forecast Period | 2024 – 2030 |
| Estimated Market Value (USD) in 2024 | $1.99 billion |
| Forecasted Market Value (USD) by 2030 | $2.88 billion |
| Compound Annual Growth Rate | 6.4% |
| Regions Covered | Global |
Key Topics Covered:
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Regional outlook
2.4. Competitive Insights
Chapter 3. Dogs Vaccines Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising pet ownership and pet humanization
3.2.1.2. Increasing concerns over zoonotic diseases
3.2.1.3. Technological advancements
3.2.1.4. Initiatives by market participants
3.2.2. Market Restraint Analysis
3.2.2.1. Lack of adoption of immunization in endemic countries
3.3. Dogs Vaccines Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.2. PESTEL Analysis
3.4. Regulatory Framework
3.5. Pricing Analysis
3.6. COVID-19 impact Analysis
Chapter 4. Dogs Vaccines Market: Duration of Immunity Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Dogs Vaccines Market: Duration of Immunity Movement Analysis
4.3. Dogs Vaccines Market by Duration of Immunity Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. 1 year
4.6. 3 years
4.7. Others
Chapter 5. Dogs Vaccines Market: Vaccine Type Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Dogs Vaccines Market: Vaccine Type Movement Analysis
5.3. Dogs Vaccines Market by Vaccine Type Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Modified/ Attenuated Live
5.6. Inactivated (Killed)
5.7. Other Vaccines
Chapter 6. Dogs Vaccines Market: Disease Type Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Dogs Vaccines Market: Disease type Movement Analysis
6.3. Dogs Vaccines Market by Disease type Outlook (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. Canine Distemper
6.6. Canine Infectious Respiratory Disease Complex (CIRDC)
6.7. Canine Parvovirus/ Parvovirus Disease
6.8. Canine Leptospirosis
6.9. Canine Lyme Disease
6.10. Infectious Canine Hepatitis
6.11. Canine Rabies
6.12. Other Diseases
Chapter 7. Dogs Vaccines Market: Route of Administration Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Dogs Vaccines Market: Route of Administration Movement Analysis
7.3. Dogs Vaccines Market by Route of Administration Outlook (USD Million)
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5. Injectable
7.6. Intranasal
7.7. Oral
Chapter 8. Dogs Vaccines Market: Component Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Dogs Vaccines Market: Component Movement Analysis
8.3. Dogs Vaccines Market by Component Outlook (USD Million)
8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
8.5. Combined Vaccines
8.6. Mono Vaccines
Chapter 9. Dogs Vaccines Market: Distribution Channel Estimates & Trend Analysis
9.1. Segment Dashboard
9.2. Dogs Vaccines Market: Distribution Channel Movement Analysis
9.3. Dogs Vaccines Market by Distribution Channel Outlook (USD Million)
9.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
9.5. Retail
9.6. E-Commerce
9.7. Hospital/Clinic Pharmacies
Chapter 10. Dogs Vaccines Market: Regional Estimates & Trend Analysis
10.1. Regional Dashboard
10.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
10.3. North America
10.4. Europe
10.5. Asia Pacific
10.6. Latin America
10.7. MEA
Chapter 11. Competitive Landscape
11.1. Company Categorization
11.2. Recent Developments & Impact Analysis by Key Market Participants
11.3. Company Market Share Analysis, 2024
11.4. Company overview
- Zoetis
- Boehringer Ingelheim
- Merck
- Elanco
- Virbac
- Bioveta
- Hester Biosciences
- Brilliant Bio Pharma
- Heska
- Zendal Group
For more information about this report visit https://www.researchandmarkets.com/r/69fci9
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
This post was originally published on this site be sure to check out more of their content.
